h1

h2

h3

h4

h5
h6


001     1011753
005     20250621051345.0
024 7 _ |a 0262-0898
|2 ISSN
024 7 _ |a 1573-7276
|2 ISSN
024 7 _ |a SCOPUS:2-s2.0-105003679938
|2 SCOPUS
024 7 _ |a WOS:001476232100001
|2 WOS
024 7 _ |a 10.1007/s10585-025-10344-3
|2 doi
024 7 _ |a pmid:40285820
|2 pmid
024 7 _ |a 10.18154/RWTH-2025-04703
|2 datacite_doi
037 _ _ |a RWTH-2025-04703
041 _ _ |a English
082 _ _ |a 610
100 1 _ |0 P:(DE-82)1013282
|a Seyfried, Lisa
|b 0
|u rwth
245 _ _ |a Enhancing tumor control in liver metastases treated with SBRT: dosimetric predictors and clinical outcomes from a single-center analysis
|h online, print
260 _ _ |a Dordrecht
|b Springer Science + Business Media B.V.
|c 2025
300 _ _ |a [1]-10
336 7 _ |0 0
|2 EndNote
|a Journal Article
336 7 _ |0 PUB:(DE-HGF)16
|2 PUB:(DE-HGF)
|a Journal Article
|b journal
|m journal
336 7 _ |2 BibTeX
|a ARTICLE
336 7 _ |2 DRIVER
|a article
336 7 _ |2 DataCite
|a Output Types/Journal article
336 7 _ |2 ORCID
|a JOURNAL_ARTICLE
536 _ _ |0 G:(DE-82)021000-OAPKF
|a OAPKF - Open-Access-Publikation mit Unterstützung der RWTH Aachen University (021000-OAPKF)
|c 021000-OAPKF
|x 0
588 _ _ |a Dataset connected to CrossRef, Journals: publications.rwth-aachen.de
591 _ _ |a Germany
700 1 _ |0 P:(DE-82)006191
|a Eble, Michael J.
|b 1
|u rwth
700 1 _ |0 P:(DE-82)IDM06554
|a Mohamed, Ahmed Allam
|b 2
|e Corresponding author
|u rwth
773 _ _ |0 PERI:(DE-600)1496876-9
|a 10.1007/s10585-025-10344-3
|n 3
|p 28
|t Clinical & experimental metastasis
|v 42
|x 1573-7276
|y 2025
856 4 _ |u https://publications.rwth-aachen.de/record/1011753/files/1011753.pdf
|y OpenAccess
876 7 _ |c 100
|d 2025-05-15
|e Other
|j DEAL
|v 7.00
|x 021000-936610
|z Servicepauschale
876 7 _ |c 2600
|d 2025-05-15
|e Hybrid-OA
|j DEAL
|v 182.00
|x 021000-936610
909 C O |o oai:publications.rwth-aachen.de:1011753
|p openaire
|p open_access
|p OpenAPC_DEAL
|p driver
|p VDB
|p openCost
|p dnbdelivery
910 1 _ |0 I:(DE-588b)36225-6
|6 P:(DE-82)1013282
|a RWTH Aachen
|b 0
|k RWTH
910 1 _ |0 I:(DE-588b)36225-6
|6 P:(DE-82)006191
|a RWTH Aachen
|b 1
|k RWTH
910 1 _ |0 I:(DE-588b)36225-6
|6 P:(DE-82)IDM06554
|a RWTH Aachen
|b 2
|k RWTH
914 1 _ |y 2025
915 1 _ |0 StatID:(DE-HGF)0031
|2 StatID
|a Peer reviewed article
|x 0
915 p c |0 PC:(DE-HGF)0000
|2 APC
|a APC keys set
915 p c |0 PC:(DE-HGF)0001
|2 APC
|a Local Funding
915 p c |0 PC:(DE-HGF)0002
|2 APC
|a DFG OA Publikationskosten
915 p c |0 PC:(DE-HGF)0113
|2 APC
|a DEAL: Springer Nature 2020
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2024-12-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2024-12-10
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CLIN EXP METASTAS : 2022
|d 2024-12-10
915 _ _ |a DEAL Springer
|0 StatID:(DE-HGF)3002
|2 StatID
|d 2024-12-10
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-10
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2024-12-10
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2024-12-10
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2024-12-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2024-12-10
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2024-12-10
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-10
920 1 _ |0 I:(DE-82)532030-2_20140620
|k 532030-2 ; 936610
|l Klinik und Lehrstuhl für Radioonkologie und Strahlentherapie
|x 0
980 _ _ |a APC
980 _ _ |a I:(DE-82)532030-2_20140620
980 _ _ |a UNRESTRICTED
980 _ _ |a VDB
980 _ _ |a journal
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21